共 50 条
- [21] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1GENOME MEDICINE, 2013, 5Nies, Anne T.Niemi, MikkoBurk, OliverWinter, StefanZanger, Ulrich M.Stieger, BrunoSchwab, MatthiasSchaeffeler, Elke
- [22] Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1PHARMACOGENETICS AND GENOMICS, 2008, 18 (07): : 559 - 568Oswald, StefanKoenig, JoergLuetjohann, DieterGiessmann, ThomasKroemer, Heyo K.Rimmbach, ChristianRosskopf, DieterFromm, Martin F.Siegmund, Werner
- [23] The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3DRUG METABOLISM AND DISPOSITION, 2007, 35 (05) : 779 - 786Seithel, AnnickEberl, SonjaSinger, KatrinAuge, DanielHeinkele, GeorgWolf, Nadine B.Doerje, FrankFromm, Martin F.Koenig, Joerg
- [24] Characteization of OATP1B1 and OATP1B3 inhibition by NilotinibFASEB JOURNAL, 2019, 33Sprowl, Jason A.Chen, MingqingGibson, Alice A.Pasquariello, Kyle Z.Sparreboom, AlexHu, Shuiying
- [25] The Role of Polymorphisms for the Substrate-Dependent Uptake Kinetics of Oatp1b1BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (06) : 498 - 498Koenig, JoergSeithel, AnnickBrockmeier, DierkFromm, Martin F.
- [26] Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters OATP1B1, OATP1B3, OATP2B1 and NTCPBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (02) : 81 - 86Koenig, JoergKlatt, SabineDilger, KarinFromm, Martin F.
- [27] Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter ActivityPharmaceutical Research, 2023, 40 : 2639 - 2651Yeamin HuhAnna PlotkaHua WeiJulia KaplanNancy RahaJustin TownerVivek S. PurohitMartin E. DowtyRobert WolkManoli VourvahisAmanda King-AhmadSumathy MathialaganMark A. WestSarah LazzaroSangwoo RyuA. David Rodrigues
- [28] The effect of well-known inhibitors of efflux transporters on the uptake transporters, OATP1B1 and OATP1B3DRUG METABOLISM REVIEWS, 2006, 38 : 60 - 61Matsushima, SoichiroMaeda, KazuyaSugiyama, Yuichi
- [29] Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter ActivityPHARMACEUTICAL RESEARCH, 2023, 40 (11) : 2639 - 2651Huh, YeaminPlotka, AnnaWei, HuaKaplan, JuliaRaha, NancyTowner, JustinPurohit, Vivek S.Dowty, Martin E.Wolk, RobertVourvahis, ManoliKing-Ahmad, AmandaMathialagan, SumathyWest, Mark A.Lazzaro, SarahRyu, SangwooRodrigues, A. David
- [30] Interaction of Digitalis-Like Compounds with Liver Uptake Transporters NTCP, OATP1B1, and OATP1B3MOLECULAR PHARMACEUTICS, 2014, 11 (06) : 1844 - 1855Gozalpour, ElnazGreupink, RickWortelboer, Heleen M.Bilos, AlbertSchreurs, MariekeRussel, Frans G. M.Koenderink, Jan B.